US Bancorp
BVS icon

US Bancorp’s Bioventus BVS Stock Holding History

US Bancorp’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51
Closed -$466 – 4185
2026
Q1 		$466 Buy
+51
New +$428 ﹤0.01% 4013
2024
Q4 		– Sell
-9,267
Closed -$111K – 4168
2024
Q3 		$111K Hold
9,267
– – ﹤0.01% 2345
2024
Q2 		$53.3K Buy
+9,267
New +$50.8K ﹤0.01% 2639
2022
Q4 		– Sell
-154
Closed -$1K – 4151
2022
Q3 		$1K Buy
+154
New +$1.21K ﹤0.01% 3920
2022
Q2 		– Sell
-63
Closed -$1K – 4089
2022
Q1 		$1K Buy
+63
New +$843 ﹤0.01% 3919
2021
Q4 		– Sell
-39
Closed -$1K – 4103
2021
Q3 		$1K Buy
+39
New +$600 ﹤0.01% 3959

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

US Bancorp's BVS Position: Q2 2026 in Review

US Bancorp sold out of Bioventus (BVS) in Q2 2026, closing a stake of 51 shares — an estimated $466 sold.

US Bancorp first reported a position in BVS in Q3 2021 and held it in 6 quarters. The position peaked at $111K in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • US Bancorp reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 51 Bioventus shares in Q2 2026, an estimated $466.
  • US Bancorp first reported a position in Bioventus in Q3 2021 and held it in 6 quarters.
  • US Bancorp's Bioventus position peaked at $111K in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.